Publication

Tisotumab vedotin in previously treated recurrent or metastatic cervical cancer

Hong, DS
; 
Concin, N
; 
Vergote, I
; 
de Bono, JS
; 
Slomovitz, BM
; 
Drew, Y
; 
Arkenau, HT
; 
Machiels, JP
; 
Spicer, JF
; 
Jones, R
... show 10 more
Citations
Altmetric:
Abstract
Authors
Hong, DS
Concin, N
Vergote, I
de Bono, JS
Slomovitz, BM
Drew, Y
Arkenau, HT
Machiels, JP
Spicer, JF
Jones, R
Forster, MD
Cornez, N
Gennigens, C
Johnson, ML
Thistlethwaite, Fiona C
Rangwala, RA
Ghatta, S
Windfeld, K
Harris, JR
Lassen, UN
Coleman, RL
Affiliation
Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Description
Date
2020
Publisher
Collections
All Paterson Institute for Cancer Research
Show all metadata
Keywords
Type
Article
Citation
Hong DS, Concin N, Vergote I, de Bono JS, Slomovitz BM, Drew Y, et al. Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer. Clin Cancer Res. 2020;26(6):1220-8.
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/622966
Embedded videos